Company: TVRD
Filing Date: 2025-10-14
Form Type: 8-K
Source: 0001104659-25-098908
Chunk: 0

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-14
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On October 13, 2025,
Tvardi Therapeutics, Inc. issued a press release entitled “ Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2
REVERT Trial in Idiopathic Pulmonary Fibrosis.” The full text of the press release is attached as Exhibit 99.1 to this Current Report
on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.